Study reveals geographic and sociodemographic factors driving epilepsy incidence among older U.S. adults, highlighting regional disparities and associated risk factors.
CMS sets 2027 maximum fair prices for 15 high-cost Medicare drugs, cutting costs by up to 85% and saving $12 billion annually under Inflation Reduction Act measures.
CMS introduces the ACCESS payment model to provide Medicare beneficiaries with chronic conditions greater access to technology-driven care, shifting from fee-for-service to outcome-based payments.
Survey finds 77% of Americans satisfied with 2026 health plans despite premium hikes; AI tools gain traction in insurance shopping.
Discover critical factors driving retirees to reconsider Medicare Advantage plans in 2025, including network constraints, pre-authorization challenges, and coverage gaps compared to traditional Medicare and Medigap options.
Geisinger Health System hosts Medicare Advantage plan sessions to guide seniors before the Dec. 7 enrollment deadline. Geisinger Gold earns high CMS ratings with extensive network and member benefits.
The Increasing Medication Access for Seniors Act of 2025 proposes interest-free monthly payments for costly Medicare prescriptions, improving affordability and transparency in the Medicare Prescription Payment Plan.
Novo Nordisk's semaglutide drugs face significant Medicare price reductions under CMS negotiation rules starting 2027, but new indications could drive future revenue growth.
CMS announces the ACCESS Model, a 10-year initiative starting in 2026 to advance technology-supported, outcomes-based care for Medicare beneficiaries with chronic conditions, emphasizing performance-driven payments and regulatory compliance.
The House Veterans’ Affairs Committee reviews bills addressing funding for veterans benefits and healthcare, focusing on VA loan fees and Medicare Advantage reimbursements to reduce duplicative spending and improve care financing.
